MicroRNA-301b promotes cell invasiveness through targeting TP63 in pancreatic carcinoma cells

International Journal of Oncology

Volumn 44, Issue 3, 2014, Pages 725-734

  Funamizu, Naotake ^a   Lacy, Curtis Ray ^b   Parpart, Sonya T ^c   Takai, Atsushi ^d   Hiyoshi, Yukiharu ^e   Yanaga, Katsuhiko ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

^d KYOTO UNIVERSITY   (Japan)

^e KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Micro RNA 301b; Pancreatic carcinoma; TP63

Indexed keywords

GEMCITABINE; MICRORNA; MICRORNA 301B; PROTEIN; TP63 PROTEIN; UNCLASSIFIED DRUG;

ALGORITHM; ARTICLE; CANCER CELL CULTURE; CANCER THERAPY; CARCINOMA CELL; CELL INVASION; CONTROLLED STUDY; PANCREATIC CARCINOMA CELL; PRIORITY JOURNAL;

CELL PROLIFERATION; DEOXYCYTIDINE; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; NF-KAPPA B; PANCREATIC NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 84896715173     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2243     Document Type: Article

References (33)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al: Cancer statistics, 2009. CA Cancer J Clin 59: 225-249, 2009.
2. Eltawil KM, Renfrew PD and Molinari M: Meta-analysis of phase III randomized trials of molecular targeted therapies for advanced pancreatic cancer. HPB (Oxford) 14: 260-268, 2012.
3. Li D, Xie K, Wolff R and Abbruzzese JL: Pancreatic cancer. Lancet 363: 1049-1057, 2004.
4. Bartel D: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
5. Piepoli A, Tavano F, Copetti M, Mazza T, Palumbo O, et al: MiRNA expression profiles identify drivers in colorectal and pancreatic cancers. PLoS One 7: e33663, 2012.
6. Nikitina EG, Urazova LN and Stegny VN: MicroRNAs and human cancer. Exp Oncol 34: 2-8, 2012.
7. Iorio MV and Croce CM: MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med 4: 143-159, 2012.
8. Li C, Hashimi SM, Good DA, Cao S, Duam W, et al: Apoptosis and microRNA aberrations in cancer. Clin Exp Pharmacol Physiol 39: 739-746, 2012.
9. Garofalo M, Romano G, Di Leva G, Nuovo G, Jeon YJ, et al: EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers. Nat Med 18: 74-82, 2011.
10. Wu Y, Xiao Y, Ding X, Zhuo Y, Ren P, et al: A miR-200b/200c/429-binding site polymorphism in the 3′ untranslated region of the AP-2α gene is associated with cisplatin resistance. PLoS One 6: e29043, 2011.
11. Lee EJ, Gusev Y, Jiang J, Nuovo GJ, Lerner MR, et al: Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer 120: 1046-1054, 2007.
12. Jiang J, Gusev Y, Aderca I, Mettler TA, Nagorney DM, et al: Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res 14: 419-427, 2008.
13. Miko E, Czimmerer Z, Csánky E, Boros G, Buslig J, et al: Differentially expressed microRNAs in small cell lung cancer. Exp Lung Res 35: 646-664, 2009.
14. Lu YC, Chen YJ, Wang HM, Tsai CY, Chen WH, et al: Oncogenic function and early detection potential of miRNA-10b in oral cancer as identified by microRNA profiling. Cancer Prev Res 5: 665-674, 2012.
15. Wang YX, Zhang XY, Zhang BF, Yang CQ, Chen XM and Gao HJ: Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis. J Dig Dis 11: 50-54, 2010.
16. Cao G, Huang B, Liu Z, Zhang J, Xu H, et al: Intronic miR-301 feedback regulates its host gene, ska2, in A549 cells by targeting MEOX2 to affect ERK/CREB pathways. Biochem Biophys Res Commun 396: 978-982, 2010.
17. Shi W, Gerster K, Alajez NM, Tsang J, Waldron L, et al: MicroRNA-301 mediates proliferation and invasion in human breast cancer. Cancer Res 71: 2926-2937, 2011.
18. Lu Z, Li Y, Takwi A, Li B, Zhang J, et al: miR-301a as an NF-κB activator in pancreatic cancer cells. EMBO J 30: 57-67, 2011.
19. Funamizu N, Okamoto A, Kamata Y, Misawa T, Uwagawa T, et al: Is the resistance of gemcitabine for pancreatic cancer settled only by overexpression of deoxycytidine kinase? Oncol Rep 23: 471-475, 2010.
20. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, et al: p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 2: 305-316, 1998.
21. Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, et al: p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398: 714-718, 1999.
22. Yuan M, Luong P, Hudson C, Gudmundsdottir K and Basu S: c-Abl phosphorylation of ΔNp63α is critical for cell viability. Cell Death Dis 1: e16, 2010.
23. Helton ES, Zhang J and Chen X: The proline-rich domain in p63 is necessary for the transcriptional and apoptosis-inducing activities of TAp63. Oncogene 27: 2843-2850, 2010.
24. Gressner O, Schilling T, Lorenz K, Schulze Schleithoff E, Koch A, et al: TAp63alpha induces apoptosis by activating signaling via death receptors and mitochondria. EMBO J 24: 2458-2471, 2005.
25. Guo X, Keyes WM, Papazoglu C, Zuber J, Li W, et al: TAp63 induces senescence and suppresses tumorigenesis in vivo. Nat Cell Biol 11: 1451-1457, 2009.
26. Chiang CT, Chu WK, Chow SE and Chen JK: Overexpression of delta Np63 in a human nasopharyngeal carcinoma cell line downregulates CKIs and enhances cell proliferation. J Cell Physiol 219: 117-122, 2009.
27. Schavolt KL and Pietenpol JA: p53 and Delta Np63 alpha differentially bind and regulate target genes involved in cell cycle arrest, DNA repair and apoptosis. Oncogene 26: 6125-6132, 2007.
28. Sen T, Sen N, Huang Y, Sinha D, Luo ZG, et al: Tumor protein p63/nuclear factor κB feedback loop in regulation of cell death. J Biol Chem 286: 43204-43213, 2011.
29. Wu J, Bergholz J, Lu J, Sonenshein GE and Xiao ZX: TAp63 is a transcriptional target of NF-kappaB. J Cell Biochem 109: 702-710, 2010.
30. Hayden MS and Ghosh S: Shared principles in NF-kappaB signaling. Cell 132: 344-362, 2008.
31. Chua HL, Bhat-Nakshatri P, Clare SE, Morimiya A, Badve S and Nakshatri H: NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2. Oncogene 26: 711-724, 2007.
32. Funamizu N, Kamata Y, Misawa T, Uwagawa T, Lacy CR, et al: Hydroxyurea decreases gemcitabine resistance in pancreatic carcinoma cells with highly expressed ribonucleotide reductase. Pancreas 41: 107-113, 2010.
33. Funamizu N, Lacy CR, Fujita K, Furukawa K, Takeyuki M, et al: Tetrahydrouridine inhibits cell proliferation through cell cycle regulation regardless of cytidine deaminase expression levels. PLoS One 7: e37424, 2012.